Karonic Anhydride CAS 67911-21-1 PF-07321332 Boceprevir Entèmedyè Segondè Kalite
Pwovizyon Komèsyal PF-07321332 Paxlovid ki gen rapò ak Entèmedyè ak kalite siperyè
L-tèt-Leucine (H-Tle-OH) CAS 20859-02-3
Karonic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic asid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0]hexane CAS 943516-54-9
Non Chimik | Anidrid kawonyen |
Sinonim | 6,6-Dimethyl-3-oxabicyclo [3.1.0] hexane-2,4-dyon;3,3-Dimethyl-1,2-cyclopropanedicarboxylic Anhydride |
Nimewo CAS | 67911-21-1 |
Nimewo CAT | RF-PI315 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn Chak Mwa |
Fòmil molekilè | C7H8O3 |
Pwa molekilè | 140.14 |
Pwen k ap fonn | 53.0 ~ 57.0 ℃ |
Pwen bouyi | 246°C |
Pwen flache | 113°C |
Dansite | 1.274 g/mL nan 25 ° C |
Solibilite | Soluble nan metanol |
Depo ak sansiblite | Imidite sansib.Sere anba Azòt.Tanperati anbyen. |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud kristal blan oswa prèske blan |
Pèt sou siye | ≤0.50% |
Rezid sou ignisyon | ≤0.20% |
Single enpurte | ≤0.50% |
Enpurte total | ≤2.0% |
Pite / Metòd analiz | ≥98.0% (GC) |
Metal lou (Pb) | ≤20ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan PF-07321332 Paxlovid (CAS 2628280-40-8) ak Boceprevir (CAS 394730-60-0) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan anidrid karonic (CAS: 67911-21-1) ak bon jan kalite segondè, lajman ki itilize nan sentèz òganik, sentèz entèmedyè pharmaceutique ak aktif famasetik engredyan (API) sentèz.Karonic Anhydride se entèmedyè kle nan PF-07321332 Paxlovid (CAS 2628280-40-8) ak Boceprevir (CAS 394730-60-0).PF-07321332 se yon inibitè ki pisan ak oralman aktif SARS-CoV 3C-tankou proteaz (3CLPRO) devlope pa Pfizer.PF-07321332 vize viris SARS-CoV-2 epi li ka itilize pou rechèch COVID-19.Boceprevir se yon inibitè NS3 serine proteaz nan viris epatit C, pou tretman enfeksyon HCV.